Geno Germano, Group President, Global Innovative Pharma Business, Pfizer.  In this capacity Mr. Germano is focused on development and commercialization of novel medicines that significantly improve patients’ lives. In this role, Germano leads a growing global business with market-leading medicines and a robust pipeline in several therapeutic areas including inflammation, cardiovascular and metabolic disease, neuroscience and pain and rare diseases. Additionally, Germano is Co-Chair of the Portfolio Strategy and Investment Committee that focuses on maximizing the return on research and development investment across the Pfizer Inc. portfolio.